Adamas Pharmaceuticals reported -19518000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Aerie Pharmaceuticals AERI:US $ -33.31M 2.2M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Intra Cellular Therapies ITCI:US $ -76.93M 8.21M
Marinus Pharmaceuticals MRNS:US $ -19.51M 4.32M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novartis NOVN:VX SF 4544M 120M
Omeros OMER:US $ -22703000 5.89M
Prothena PRTA:US $ 109.2M 81.3M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Teva Pharmaceutical TEVA:IT 382M 412M
Zogenix ZGNX:US $ -58M 0.89M